xanthenes has been researched along with Ischemic Stroke in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, H; Chen, X; Fu, S; He, Y; Liu, H; Shen, J; Wang, Q | 1 |
1 other study(ies) available for xanthenes and Ischemic Stroke
| Article | Year |
|---|---|
Proteomics-Guided Study on Buyang Huanwu Decoction for Its Neuroprotective and Neurogenic Mechanisms for Transient Ischemic Stroke: Involvements of EGFR/PI3K/Akt/Bad/14-3-3 and Jak2/Stat3/Cyclin D1 Signaling Cascades.
Topics: 14-3-3 Proteins; Animals; Apoptosis; Astrocytes; Axons; bcl-Associated Death Protein; Caveolin 1; Cell Differentiation; Cell Proliferation; Cyclin D1; Down-Regulation; Drugs, Chinese Herbal; ErbB Receptors; Ischemic Attack, Transient; Ischemic Stroke; Janus Kinase 2; Male; Memory; Neural Stem Cells; Neuritis; Neurogenesis; Neuroprotection; Neuroprotective Agents; PC12 Cells; Phosphatidylinositol 3-Kinases; Proteomics; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Recovery of Function; Reperfusion Injury; Signal Transduction; STAT3 Transcription Factor; Transcription Factor HES-1; Up-Regulation; Xanthenes | 2020 |